Literature DB >> 4415589

Response of adult patients with osteomalacia to treatment with crystalline 1alpha-hydroxy vitamin D3.

P Bordier, M M Pechet, R Hesse, P Marie, H Rasmussen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4415589     DOI： 10.1056/NEJM197410242911702

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Treatment of osteomalacia with oral 1-alpha-hydroxyvitamin D3 in a patient with malabsorption.

Authors:  J E Compston; L W Horton; J R Tighe
Journal:  Br Med J       Date:  1977-09-03

2.  Failure to heal D-deficiency rickets and suppress secondary hyperparathyroidism with conventional doses of 1,25-dihydroxy vitamin D3.

Authors:  T Cundy; J A Kanis; G Heynen; M Earnshaw; T L Clemens; J L O'Riordan; A L Merrett; J E Compston
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-20

3.  Studies on the mode of action of vitamin D XXXVII 1 alpha-hydroxyvitamin D3: a long-acting 1,25-dihydroxyvitamin D3 analog.

Authors:  M R Walters; W Hunziker; J E Bishop; A W Norman
Journal:  Calcif Tissue Int       Date:  1983-05       Impact factor: 4.333

4.  MKP-1 is essential for canonical vitamin D-induced signaling through nuclear import and regulates RANKL expression and function.

Authors:  Alfred C Griffin; Michael J Kern; Keith L Kirkwood
Journal:  Mol Endocrinol       Date:  2012-08-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.